日本黄色小说视频,日韩在线一区二区三区免费视频,亚洲电影在线,精品欧美日韩一区二区三区,久久香蕉国产线看观看亚洲卡,美女浴室,美女脱衣诱惑

資訊|論壇|病例

搜索

首頁 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫 醫(yī)學(xué)會議

您所在的位置:首頁 > 血液科專家課件 > Myelodysplastic syndrome

Myelodysplastic syndrome

2013-10-24 21:20 閱讀:1508 來源:愛愛醫(yī) 責(zé)任編輯: zhima880127
[導(dǎo)讀] 《 Myelodysplasticsyndrome 》內(nèi)容預(yù)覽: (點(diǎn)擊下圖可閱讀全部內(nèi)容) It is a term for a heterogeneous collection of haemopoietic stem cell disorders affecting older **s. There is underlying ineffectiveness of haemopoiesis that results in

Myelodysplastic syndrome 內(nèi)容預(yù)覽:

 (點(diǎn)擊下圖可閱讀全部內(nèi)容) 

    It is a term for a heterogeneous collection of haemopoietic stem cell disorders affecting older adults.
    There is underlying ineffectiveness of haemopoiesis that results in dysplasia of bone marrow precursors and pe**heral cytopenias.

    Moderate anaemia is the most common clinical problem in MDS patients, but complete myeloid bone marrow failure also occurs leading to death from bleeding or infection.
    Approximately half of the patients transform to AML.

    Prognosis depends on the individual’s risk factors, with median survival ranging from 5.7 years in lower-risk group to 1.2 years or less in those with higher-risk MDS.
    MDS is extremely difficult to treat. Most cases are resistant to current therapies, and the most potent anti-MDS treatments (transplantation and dose intensive chemotherapy) are often too toxic for the majority of patients.

    The WHO proposed changes including reclassification of RAEB-t to AML and adding a subgroup called refractory cytopenias with dysplasia (RCD)

點(diǎn)擊下載完整版:《Myelodysplastic syndrome》 


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進(jìn)行刪除處理

意見反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved